Mergers and Acquisitions in the IVD Market

• Executive Summary
  • The Market Landscape
  • Mergers and Acquisitions
  • Methodology
• IVD Mergers and Acquisitions
  • Introduction
    • Table Selected Acquisitions of Diagnostic Companies, 2015-2016
  • Select Top Tier IVD Company Activities in 2015 and 2016
    • The Proposed Acquisition of Alere by Abbott
    • Roche Remains Active in M&A
    • Siemens' Plan to Divest Its Healthcare Business, Siemens Healthineers
    • Danaher's Acquisition of Molecular Diagnostics Leader Cepheid
    • Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation Strength
    • Thermo Fisher Scientific Acquires Affymetrix
    • Beckman Coulter Acquires Siemens Healthcare Diagnostics' Clinical Microbiology Business
    • Becton Dickinson (BD) Prepares Its Entrance into Sequencing with Cellular Research Acquisition
  • Other 2015-2016 Acquisitions of Note
    • Luminex's Acquisition of Nanosphere
    • Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal
    • IBM Healthcare/Watson Continues Expansion
  • Select 2013-2014 Acquisitions of Note
    • Abbott Diagnostics
    • Johnson and Johnson (J&J)
    • Thermo Fisher
      • Table Selected Acquisitions of Diagnostic Companies, 2013-2014
    • Becton Dickinson
    • bioMérieux
    • Bio-Rad Laboratories
    • Arkray
    • QIAGEN
    • Radiometer
    • Trinity Biotech
    • Grifols International

Mergers and Acquisitions in the IVD Market

Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.